Guest Speaker, Global Senior Director Study Management Astra-Zeneca.
A MD – graduate of Medical Academy in Katowice and Medical Academy in Warsaw. In 2009 she obtained the diploma with distinction from the Wyższa Szkoła Zarządzania – Polish Open University and Oxford Brookes University. She has worked with clinical studies and development in Poland since 1997.
She started her carrier as the Clinical Research Associate at Parexel. Since 1999 she is responsible for organizing, monitoring, and managing the processes and quality of clinical trials in AstraZeneca. Alina was the Clinical Research Director. She was the first Director of the Clinical Operations Hub in Warsaw, who was coordinating global trials.
In 2012-2015 as Global Director of Site Management & Monitoring, she was leading the clinical trials over the Europe, Middle East & Africa regions.
From the beginning of 2016, Alina moved to Gothenburg, Sweden as the Global Senior Director of Clinical Operations. While holding that position, she developed, implemented, and maintained a strategy for clinical operations across Cardiovascular, Chronic Kidney, and Gastrointestinal compounds, and provide portfolio-level leadership to drive clinical programs and studies.
She was leading a group of Directors of Clinical Development (DCD) and Associate Directors of Clinical Development (ADCD).
Afterward, in October 2017, Alina moved back to Warsaw, after becoming appointed to the role of Global Head of Study Management Operations, taking over Warsaw, Toronto, and Shanghai Hubs within over 350 global project teams in Clinical Operations.
Currently, she is focusing on research management in the area of respiratory, metabolic, and cardiological diseases.
In the meantime, Alina also became a Vice-President of AstraZeneca Pharma Poland, having the opportunity of shaping the Warsaw office and influencing its growth.